NDC 51672-4044-01 - Clorazepate Dipotassium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-4044
- Requested NDC
- 51672-4044-01
- Package NDCs from labels
- 51672-4044-1, 51672-4044-2, 51672-4044-3, 51672-4044-01
- Manufacturer
- PD-Rx Pharmaceuticals, Inc.
- Effective date
- 2026-09-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Clorazepate Dipotassium Tablets USP 15 mg | PD-Rx Pharmaceuticals, Inc. | 2026-09-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Clorazepate Dipotassium - Clinical Solutions Wholesale, LLC | Clinical Solutions Wholesale, LLC | 2026-07-24 | HUMAN PRESCRIPTION DRUG LABEL |
| Clorazepate Dipotassium Tablets USP, 3.75 mg, 7.5 mg, & 15 mg | Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries, Ltd. | 2026-07-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Clorazepate Dipotassium - Coupler LLC | Coupler LLC | 2025-01-28 | HUMAN PRESCRIPTION DRUG LABEL |
| Clorazepate Dipotassium Tablets USP, 15 mg | PD-Rx Pharmaceuticals, Inc. | 2025-01-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-4044-1 | Clorazepate Dipotassium | 100 in 1 BOTTLE | TABLET | 100 | 7 | |
| 51672-4044-2 | Clorazepate Dipotassium | 500 in 1 BOTTLE | TABLET | 500 | 7 | |
| 51672-4044-3 | Clorazepate Dipotassium | 1000 in 1 BOTTLE | TABLET | 1000 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-4044 | CLORAZEPATE DIPOTASSIUM TABLET [TARO PHARMACEUTICALS U.S.A., INC.] | 7 | Current NDC, Legacy NDC, 3 package rows | 20240926_499a6989-8912-44b7-b1eb-ee8f85ae378f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-4044-1 | EA - Each | 51672-4044 | 2dca8912-9c73-4790-a352-6b367bfb3b20 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fungus Fighter | CANDIDA ALBICANS, SANICULA, TELLURIUM METALLICUM, TORULA CEREVISIAE, ANTIMON. CRUD., ARSENICUM ALB., BARYTA CARB., BRYONIA, CALC. CARB., CARBO VEG., CUPRUM MET., DULCAMARA, GRAPHITES, KALI CARB., LACHESIS, LYCOPODIUM, MEZEREUM, NITRICUM AC., PHOSPHORUS, PHYTOLACCA, SEPIA, SILICEA, SULPHUR, SULPHURICUM AC., ZINC. MET., APIS MEL., THUJA OCC. | Newton Laboratories, Inc. | 9b4276af-b738-3293-e053-2a95a90ad022 | 2025-08-19 | Warnings | ETJ7Z6XBU4 BQN1B9B9HA |
| Schuessler Tissue Salts Comb D Skin Disorders | KALI MURIATICUM,KALI SULPHURICUM,CALCAREA SULPHURICA,SILICEA | Martin & Pleasance Pty Ltd | 617303f8-4463-4a1e-a502-44abc181d91f | 2025-08-13 | Warnings | ETJ7Z6XBU4 660YQ98I10 |
| Schuessler Tissue Salts Comb D Skin Disorders | KALI MURIATICUM,KALI SULPHURICUM,CALCAREA SULPHURICA,SILICEA | Martin & Pleasance Pty Ltd | 03153d92-dc68-4b84-a8c9-634b1ffd7da1 | 2025-08-13 | Warnings | ETJ7Z6XBU4 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Henry Schein, Inc. | bf8e8ac7-e6a8-4571-a0ea-7bcab89290f6 | 2025-08-12 | Warnings, Adverse reactions | 660YQ98I10 |
| Clorazepate Dipotassium | CLORAZEPATE DIPOTASSIUM | ANI Pharmaceuticals, Inc. | a4b80e69-b7c7-471a-8ce8-4e992808c669 | 2025-08-12 | Boxed warning, Warnings, Adverse reactions | 197465 197466 197464 63FN7G03XY |
| Cloveden Vegan Whitening Tooth | SILICA, HYDROGEN PEROXIDE, TOCOPHERYL ACETATE | Acuseplanet Inc | 3c04778b-9535-856e-e063-6294a90aa868 | 2025-08-10 | Warnings | ETJ7Z6XBU4 |
| Potassium Chloride | POTASSIUM CHLORIDE | AvKARE | 3bdfced1-6e62-9e92-e063-6294a90a28aa | 2025-08-08 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 3be29fcc-765e-8653-e063-6394a90a59d5 | 2025-08-08 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Slate Run Pharmaceuticals, LLC | 94ae03cc-b620-0dbb-e053-2a95a90a922c | 2025-08-07 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Slate Run Pharmaceuticals, LLC | 0cc57ece-f15a-4160-a5ea-8d6fa9f9e754 | 2025-08-07 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 47a87fb6-5e61-41c9-b759-10f7c74a67ce | 2025-08-05 | Warnings, Adverse reactions | 660YQ98I10 |
| Schuessler Tissue Salts Silica Cleanser and Conditioner 12 | SILICEA | Martin & Pleasance Pty Ltd | f70dcf90-bde9-404d-9ede-4113553ccbff | 2025-08-04 | Warnings | ETJ7Z6XBU4 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | American Health Packaging | 7956883f-0d31-4081-bbea-d9ea320a193b | 2025-08-04 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride for Oral Solution | POTASSIUM CHLORIDE FOR ORAL SOLUTION | Marlex Pharmaceuticals Inc | 3e78028d-21a0-ba0f-e063-6294a90aac49 | 2025-08-01 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride for Oral Solution | POTASSIUM CHLORIDE FOR ORAL SOLUTION | Marlex Pharmaceuticals, Inc. | 3e8a6f61-44eb-4b5a-e063-6294a90a4b1b | 2025-08-01 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE EXTENDED RELEASE | POTASSIUM CHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 3b403d60-4246-d765-e063-6394a90a12e8 | 2025-07-31 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | A-S Medication Solutions | 162a8ab5-76cf-48fa-8487-7780ed65647e | 2025-07-31 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | A-S Medication Solutions | 14db14ba-fd0d-4b2a-9f1c-a62b3b82306f | 2025-07-31 | Warnings, Adverse reactions | 660YQ98I10 |
| Cell Salts | CALC. FLUOR., CALC. PHOS., CALC.SULPH., FERRUM PHOSPHORICUM, KALI MUR., KALI PHOS., KALI SULPH., MAG. PHOS., NAT. MUR., NAT. PHOS., NAT.SULPHURICUM, SILICEA | Newton Laboratories, Inc. | 985a3341-0fe0-1dd6-e053-2a95a90ad2c5 | 2025-07-25 | Warnings | ETJ7Z6XBU4 660YQ98I10 |
| SILICA MARINA | SILICON DIOXIDE | Boiron | 3aada26e-6a8e-f545-e063-6394a90a9f80 | 2025-07-24 | ETJ7Z6XBU4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.